237
Pierrel, a global provider of the pharmaceutical industry, announced that its subsidiary Pierrel Pharma has obtained marketing authorization in Bosnia-Herzegovina for Pierrel’s flagship Articaine-based dental anesthetic, Orabloc. The group has a consolidated commercial position in the United States, Italy, Europe, the Balkans, Russia, CIS countries, as well as in Albania, Sudan, Taiwan and Indonesia. In addition, Pierrel currently markets over 32 product references in 25 different countries and has over 30 new registrations of its Orabloc anesthetic underway.